These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38435690)

  • 21. Activity of
    Valzano F; Boncompagni SR; Micieli M; Di Maggio T; Di Pilato V; Colombini L; Santoro F; Pozzi G; Rossolini GM; Pallecchi L
    Microbiol Spectr; 2022 Aug; 10(4):e0100622. PubMed ID: 35735984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients.
    Marner M; Kolberg L; Horst J; Böhringer N; Hübner J; Kresna IDM; Liu Y; Mettal U; Wang L; Meyer-Bühn M; Mihajlovic S; Kappler M; Schäberle TF; von Both U
    Microbiol Spectr; 2023 Feb; 11(1):e0443722. PubMed ID: 36692293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
    Esoda CN; Kuehn MJ
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
    [No Abstract]   [Full Text] [Related]  

  • 24. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
    Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for Complex Interplay between Quorum Sensing and Antibiotic Resistance in Pseudomonas aeruginosa.
    Sikdar R; Elias MH
    Microbiol Spectr; 2022 Dec; 10(6):e0126922. PubMed ID: 36314960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients.
    Fricks-Lima J; Hendrickson CM; Allgaier M; Zhuo H; Wiener-Kronish JP; Lynch SV; Yang K
    Int J Antimicrob Agents; 2011 Apr; 37(4):309-15. PubMed ID: 21382698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scorpionfish BPI is highly active against multiple drug-resistant
    Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S
    Elife; 2023 Jul; 12():. PubMed ID: 37461324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotics Enhance Prevention and Eradication Efficacy of Cathodic-Voltage-Controlled Electrical Stimulation against Titanium-Associated Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms.
    Canty MK; Hansen LA; Tobias M; Spencer S; Henry T; Luke-Marshall NR; Campagnari AA; Ehrensberger MT
    mSphere; 2019 May; 4(3):. PubMed ID: 31043516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL; Weiser R; Powell LC; Forton J; Mahenthiralingam E; Rye PD; Hill KE; Thomas DW; Pritchard MF
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition time plays a major role in the inhibitory effect of chitosan on the production of Pseudomonas aeruginosa virulence factors.
    Kašparová P; Boková S; Rollová M; Paldrychová M; Vaňková E; Lokočová K; Michailidu J; Maťátková O; Masák J
    Braz J Microbiol; 2022 Jun; 53(2):535-546. PubMed ID: 35235193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Hydroxypyridin-4(1
    Miao ZY; Zhang XY; Yang MH; Huang YJ; Lin J; Chen WM
    J Med Chem; 2023 Dec; 66(23):15823-15846. PubMed ID: 37978953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo antibiofilm activity of the synthetic antimicrobial peptide WLBU2 against multiple drug resistant Pseudomonas aeruginosa strains.
    Masihzadeh S; Amin M; Farshadzadeh Z
    BMC Microbiol; 2023 May; 23(1):131. PubMed ID: 37183241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
    Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
    Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in
    Imperi F; Fiscarelli EV; Visaggio D; Leoni L; Visca P
    Front Cell Infect Microbiol; 2019; 9():49. PubMed ID: 30915278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.